Literature DB >> 25027348

Management of acute dyarrhea: current and future trends.

F Franceschi1, F Scaldaferri, M E Riccioni, I Casagranda, E Forte, V Gerardi, C Cordischi, S Antonini, A Tortora, T Di Rienzo, G D'Angelo, G Merra, G Costamagna, G Zuccalà, A Gasbarrini.   

Abstract

Acute diarrhea is a very common symptom, which may recognize different causes and is basically the expression of an altered homeostasis of the bowel, which overcame current classifications. When approaching patients with acute diarrhea, we should firstly check body temperature and vital parameters and secondly provide a general medical examination mainly focused on the abdomen, in order to exclude surgical causes of diarrhea, such as acute appendicitis, diverticulitis, intestinal occlusion and others. Another important aspect is the assessment of the level of hydration in order to provide the right amount of fluids. There is no current indication for the administration of loperamide in infectious diarrhea, but there is a strong rationale for new class of drugs, which may be defined as "mucous regenerators", such as gelatin tannate. Further studies are needed on this matter in order to test the effect of gelatin tannate in adult patients with acute diarrhea.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027348

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.

Authors:  Lucio Gnessi; Vladimir Bacarea; Marius Marusteri; Núria Piqué
Journal:  BMC Gastroenterol       Date:  2015-10-30       Impact factor: 3.067

2.  Evaluation of Gelatin Tannate Against Symptoms of Acute Diarrhea in Pediatric Patients.

Authors:  Eren Çağan; Saime Ceylan; Şenay Mengi; Havva Hasret Çağan
Journal:  Med Sci Monit       Date:  2017-04-27

3.  Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis.

Authors:  Michela Campolo; Giovanna Casili; Irene Paterniti; Alessia Filippone; Marika Lanza; Alessio Ardizzone; Sarah A Scuderi; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

4.  Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical Trial.

Authors:  Cătălin Pleșea Condratovici; Vladimir Bacarea; Núria Piqué
Journal:  Gastroenterol Res Pract       Date:  2016-05-03       Impact factor: 2.260

5.  Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.

Authors:  Emanuela Esposito; Michela Campolo; Giovanna Casili; Marika Lanza; Domenico Franco; Alessia Filippone; Alessio F Peritore; Salvatore Cuzzocrea
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.